Health New Zealand Te Whatu Ora has backed down on a plan to delay free access to a life-extending cancer drug after a backlash by patients and advocates.
Health New Zealand is moving forward implementation planning to ensure a small group of cancer patients can take advantage of free early access to the drug Keytruda shortly ahead of Pharmac starting to fund the medication.
Patient advocates are accusing Health New Zealand of "cruelty" towards a small group of cancer patients, who are being forced to wait two more months for a newly-funded drug.
Experts are calling for the flu vaccine for under 12-year-olds to be fully funded - again.
Associate health minister David Seymour’s directive to Pharmac may streamline decisionmaking but it downplays the true role of the Treaty of Waitangi, writes Dominic O’Sullivan
The rollout of a national bowel cancer screening programme appears to have stalled - much to the concern of a support charity.
Associate Health Minister David Seymour’s recent letter of expectations to drug buying agency Pharmac could fundamentally change the way the organisation makes decisions. Some of these changes could also make Pharmac’s job harder and its decisions more unpopular.
Associate Health Minister David Seymour’s recent letter of expectations to drug buying agency Pharmac could fundamentally change the way the organisation makes decisions. Some of these changes could also make Pharmac’s job harder and its decisions more unpopular....
Last week, Associate Health Minister David Seymour released his letter to Pharmac setting out his expectations for the agency.
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI